Healthcare - Biotechnology - NASDAQ - CA
$ 2.01
-5.19 %
$ 35.1 M
Market Cap
-4.9
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
283.95%
EBIT
Estimate
--65.62%
Net Income
Estimate
32.17%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Lexaria Bioscience Corp.
LEXX has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart LEXX
EBIT FORECAST
EBIT Forecast Chart LEXX
NET INCOME FORECAST
Net Income Chart LEXX